3rd Quarter - Report

PODESTA GROUP, INC. for COVIDIEN

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1679 Kennedy Health Care Reform Bill Senate Finance Committee Health Care Reform Bill H.R. 3200 Tri-Committee Health Care Reform Bill S. 1213, H.R. 2502 Comparative Effectiveness Research S. 1142 Informed Health Care Decision Making Act H.R. 3276 Nuclear Medicine and Research Legislation Medical Device Safety Act of 2009 Medical Device Tax Bariatric Surgery

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
SHARON COHEN —
ARANTHAN JONES Health Policy Dir., Congressional Black Caucus
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1213 (111th), S. 1142 (111th), S. 1679 (111th), H.R. 2502 (111th), H.R. 3200 (111th), H.R. 3276 (111th)

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85 H.R. 1105 Omnibus Appropriations Act, 2009 H.R. 2346, S. 1054 Supplemental Appropriations Bill, H1N1 Pandemic H.R. 23 Budget Requirements 2010 Financial Services Appropriations Bill

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
DALE OAK New Staff Dir. House Appropriations Subcommittee
ANTHONY PODESTA —
WALTER PRYOR Legislative Director, Senator Mark Pryor
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER Legislative Director, Rep. David Scott

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2346 (111th), S. 1054 (111th), H.R. 1105 (111th), S.Con.Res. 13 (111th), H.Con.Res. 85 (111th), H.R. 1 (111th), H.R. 23 (111th)

Medicare/Medicaid MMM

S. 301 Physician Payments Sunshine Act of 2009 S. 1213, H.R. 2502 Comparative Effectiveness Research

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
SHARON COHEN —
KIMBERLEY FRITTS —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
JOHN SCOFIELD Comm. Dir., House Approps. Committee
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
MICHELLE TESSIER —

Contacted: White House Office; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Bills named: S. 1213 (111th), H.R. 2502 (111th), S. 301 (111th)

Taxation/Internal Revenue Code TAX

International tax on foreign direct investment. H..R. 1265, Stop Tax Haven Abuse Act S. 506, Stop Tax Haven Abuse Act

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
DONNI TURNER Legislative Director, Rep. David Scott

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 506 (111th)

Copyright/Patent/Trademark CPT

H.R. 1260 Patent Reform Act of 2009 S. 515 Patent Reform Act of 2009

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: SENATE; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office

Bills named: H.R. 1260 (111th), S. 515 (111th)

Pharmacy PHA

Issues Involving Controlled Substances and Pain and Addiction Drugs Generally

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
SHARON COHEN —
ARANTHAN JONES Health Policy Dir., Congressional Black Caucus
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.